Apellis Pharmaceuticals
APLS
$19.33
Share price
-0.46%
Change (1 day)
-62.47%
Change (1 year)
Categories
Revenue for Apellis Pharmaceuticals (APLS)
Revenue in 2024 (TTM): $0.78 Billion USD
According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is $0.78 Billion USD. an increase over the revenue in the year 2023 that were of $0.39 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Apellis Pharmaceuticals from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $0.78 B | 97.02% |
| 2023 | $0.39 B | 425.83% |
| 2022 | $75.42 M | 13.31% |
| 2021 | $66.56 M | -73.44% |
| 2020 | $0.25 B | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |